Latest News

Naperville, Illinois, USA. 9 October, 2023.  Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), announced it has received Investigational Device Exemption (IDE) approval from the FDA […]

Cambridge, Massachusetts, USA. 4 October 2023.  Seroba’s portfolio company, Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, today announced that it has raised $35 million in Series B funding, led by Kurma Partners’ Growth Opportunities Fund, […]

Beverly, Massachusetts, USA. 19 September 2023.  Seroba’s portfolio company, Quanta Dialysis Technologies®, a medical technology company committed to making kidney care more accessible, today announced that it has submitted a 510(k) premarket notification to the U.S. […]

Beverly, Massachusetts, U.S.A. 17 August 2023.  Seroba’s portfolio company, Quanta Dialysis Technologies®, today announced that it has completed enrollment of its Home Run study for at-home hemodialysis.  The Home Run study is a prospective, multi-center, open-label […]

Munich, Germany. 2 August 2023.  Complement Therapeutics GmbH (CTx), a preclinical stage biotechnology company developing novel therapeutics for complement-mediated diseases, has announced the appointment of Dr Parisa Zamiri as its Chief Medical Officer.  Dr. Zamiri brings […]

Beverly, Mass., USA. 3 August, 2023.  Quanta Dialysis System becomes first-in-class to perform three standard-of-care dialysis modalities in one device. Quanta Dialysis Technologies®, a medical technology company committed to making kidney care more accessible, today announced […]

We use cookies and analytics to improve your online experience and to help us to understand where our audience is and how they reach us, as well as to understand what topics and site features are of greatest interest.  To find out more, please read our Privacy Policy. By clicking on the Accept button, you consent to our use of cookies and browsing analytics.

Scroll to Top